Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-Resistance
2024 · The Oncologist · 32 citations
https://doi.org/10.1093/oncolo/oyae055
R
Riqing Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
241
Citations
7
h-index
6
i10-index
Riqing Huang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & HER2/EGFR in Cancer Research & Microstructure and Mechanical Properties of Steels. The author has an h-index of 7, co-authored 29 publications.
ORCID: 0000-0003-3618-9311Papers by this author
worksImpacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in patients with metastatic breast cancer
2025 · Journal of Translational Medicine · 5 citations
https://doi.org/10.1186/s12967-025-06082-5
Phase I study of LZM005 in patients with HER2-positive metastatic breast cancer
2022 · npj Breast Cancer · 2 citations
https://doi.org/10.1038/s41523-022-00501-2
Effect of chemotherapy alone or combined with immunotherapy for locally advanced or metastatic genitourinary small cell carcinoma: a real-world retrospective study
2023 · BMC Cancer · 1 citations
https://doi.org/10.1186/s12885-023-11473-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat